Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

palifermin

View Patient Information
A recombinant form of the endogenous human keratinocyte growth factor. Palifermin binds to epithelial cell surface receptors in the lining of the mouth and gastrointestinal tract, resulting in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:growth factor, recombinant human keratinocyte
keratinocyte growth factor, recombinant human
recombinant human keratinocyte growth factor
rhu keratinocyte growth factor
US brand name:Kepivance
Abbreviation:rhKGF
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search